Appaloosa’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-117,198
| Closed | -$31.7M | – | 43 |
|
|
2023
Q4 | $31.7M | Buy |
+117,198
| New | +$29M | 0.55% | 27 |
|
|
2023
Q2 | – | Sell |
-142,500
| Closed | -$37.6M | – | 44 |
|
|
2023
Q1 | $37.6M | Sell |
142,500
-40,000
| -22% | -$10.2M | 1.99% | 15 |
|
|
2022
Q4 | $43.8M | Buy |
182,500
+107,500
| +143% | +$24.1M | 3.25% | 10 |
|
|
2022
Q3 | $13.8M | Hold |
75,000
| – | – | 1.01% | 18 |
|
|
2022
Q2 | $12.6M | Buy |
+75,000
| New | +$16.1M | 0.79% | 21 |
|
|
2021
Q4 | – | Sell |
-387,000
| Closed | -$93.9M | – | 47 |
|
|
2021
Q3 | $93.9M | Sell |
387,000
-18,000
| -4% | -$4.4M | 2.24% | 13 |
|
|
2021
Q2 | $83.7M | Sell |
405,000
-545,000
| -57% | -$111M | 1.73% | 16 |
|
|
2021
Q1 | $179M | Sell |
950,000
-50,000
| -5% | -$8.82M | 2.57% | 10 |
|
|
2020
Q4 | $164M | Buy |
1,000,000
+65,000
| +7% | +$9.5M | 2.46% | 9 |
|
|
2020
Q3 | $117M | Sell |
935,000
-115,000
| -11% | -$14.2M | 2.06% | 13 |
|
|
2020
Q2 | $102M | Buy |
1,050,000
+765,000
| +268% | +$79.5M | 1.77% | 16 |
|
|
2020
Q1 | $25.6M | Buy |
+285,000
| New | +$36.9M | 0.78% | 18 |
|
|
2018
Q2 | – | Sell |
-282,884
| Closed | -$27.4M | – | 53 |
|
|
2018
Q1 | $27.4M | Sell |
282,884
-270,000
| -49% | -$26.2M | 0.28% | 48 |
|
|
2017
Q4 | $48.6M | Buy |
552,884
+369,173
| +201% | +$29.7M | 0.45% | 40 |
|
|
2017
Q3 | $14.6M | Buy |
183,711
+16,000
| +10% | +$1.29M | 0.21% | 39 |
|
|
2017
Q2 | $14.6M | Sell |
167,711
-320,000
| -66% | -$27.1M | 0.22% | 50 |
|
|
2017
Q1 | $43.4M | Sell |
487,711
-657,539
| -57% | -$54.8M | 0.71% | 33 |
|
|
2016
Q4 | $84.8M | Sell |
1,145,250
-91,690
| -7% | -$6.87M | 1.5% | 21 |
|
|
2016
Q3 | $93.6M | Buy |
1,236,940
+20,000
| +2% | +$1.53M | 2.12% | 15 |
|
|
2016
Q2 | $93.7M | Sell |
1,216,940
-1,956,483
| -62% | -$154M | 2.46% | 15 |
|
|
2016
Q1 | $248M | Sell |
3,173,423
-1,363,640
| -30% | -$95.2M | 4.38% | 7 |
|
|
2015
Q4 | $307M | Buy |
4,537,063
+983,526
| +28% | +$68.6M | 6.12% | 5 |
|
|
2015
Q3 | $275M | Sell |
3,553,537
-630,988
| -15% | -$55.9M | 9.6% | 2 |
|
|
2015
Q2 | $380M | Sell |
4,184,525
-722,057
| -15% | -$57.8M | 9.4% | 2 |
|
|
2015
Q1 | $369M | Sell |
4,906,582
-104,000
| -2% | -$7.47M | 6.47% | 5 |
|
|
2014
Q4 | $368M | Sell |
5,010,582
-316,300
| -6% | -$22.2M | 9.08% | 3 |
|
|
2014
Q3 | $376M | Hold |
5,326,882
| – | – | 5.54% | 5 |
|
|
2014
Q2 | $300M | Hold |
5,326,882
| – | – | 4.2% | 9 |
|
|
2014
Q1 | $280M | Buy |
5,326,882
+225,500
| +4% | +$11.2M | 3.09% | 10 |
|
|
2013
Q4 | $243M | Buy |
5,101,382
+528,300
| +12% | +$24.4M | 3.05% | 6 |
|
|
2013
Q3 | $196M | Buy |
4,573,082
+650,000
| +17% | +$25.4M | 3.11% | 7 |
|
|
2013
Q2 | $141M | Buy |
+3,923,082
| New | +$152M | 2.05% | 15 |
|
Other funds holding HCA
Appaloosa's HCA Position: Q1 2024 in Review
Appaloosa sold out of HCA Healthcare (HCA) in Q1 2024, closing a stake of 117,198 shares — an estimated $31.7M sold.
Appaloosa first reported a position in HCA in Q2 2013 and held it in 32 quarters. The position peaked at $380M in Q2 2015. 1,130 funds tracked by Wall St. Rank hold HCA as of Q1 2024.
- Appaloosa reported no remaining HCA Healthcare position as of Q1 2024 after selling out during the quarter.
- Appaloosa sold 117,198 HCA Healthcare shares in Q1 2024, an estimated $31.7M.
- Appaloosa first reported a position in HCA Healthcare in Q2 2013 and held it in 32 quarters.
- Appaloosa's HCA Healthcare position peaked at $380M in Q2 2015.
- 1,130 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2024.
Based on Appaloosa's 13F filing for Q1 2024, filed 15 May 2024.